Odili Nonso is a ‘disruptor-in-chief’ whose technologies have changed the pharmaceutical industry and established him as a force to be reckoned with in the business world. The Nigerian serial entrepreneur is often compared to Elon Musk, the billionaire founder of SpaceX and Tesla, for this very reason.
 
Nonso’s first company, which he started with just ₦150,000 ($200), disrupted the Nigerian pharmaceutical industry.
 
Now, Nonso has launched InvestiPharm Limited, Africa’s first pharma supply chain financial partner, which aims to fill the financing gap in the Nigerian pharmaceutical supply chain and help small businesses grow by providing them with the working capital they need to thrive.
 
Nonso’s passion for the pharmaceutical industry is rooted in his experience as a community pharmacist. He noticed that many small businesses in the pharmaceutical supply chain struggle to access the financing they need to grow and expand their operations, which inspired him to create InvestiPharm.
 
His focus on the pharmaceutical supply chain gives InvestiPharm a unique advantage over other crowdfunding platforms, as it is specifically designed to address the financing needs of small businesses in this industry.
 
InvestiPharm offers two financing options for funders to choose from: product financing and invoice financing. Product financing allows retailers to access quality pharmaceutical products without upfront payment, improving their cash flow, while invoice financing enables vendors to receive payment for their invoices immediately, reducing the risk of non-payment and improving their cash flow.
 
Nonso is confident in InvestiPharm’s ability to capture a significant market share and establish itself as a major player in the Nigerian crowdfunding industry. In addition to expanding its product offering to include invoice factoring and purchase order financing, InvestiPharm plans to diversify into healthcare services and offer value-added services such as telemedicine and health insurance to improve access to quality healthcare in emerging markets.
 
 
With InvestiPharm, Nonso aims to address the financing gap in the Nigerian pharmaceutical supply chain and help small businesses grow by providing them with the working capital they need to thrive.